ASAP Gets Drug Approval and Malaria Test Results: American Biotech
Labs has
just received its first international drug approval and hospital
trials have
shown outstanding results using the ASAP Solution(R) against a wide
range of
diseases including Malaria.

The Testing

Hospital testing of the ASAP Solution(R), as an antibiotic
alternative, in
Ghana, West Africa has met with such significant results that the Food
and
Drug Board of Ghana has already approved the ASAP Solution(R) for drug
registration. Testing of the product in hospitals has been going on
for over
a year, reports Keith Moeller VP, "We never dreamed that the human
testing
of the product could have gone this well. We already have results in
from
the first 60 patients, and we are waiting for information on
approximately
120 more."

In the testing, which was conducted in hospitals by medical doctors,
the
ASAP Solution(R) was used as a treatment for a variety of diseases and
conditions such as malaria, fungal skin infections, vaginal
infections,
urinary tract infections, tonsilitis, pharingitis, gonorrhea,
conjunctivitis, upper respiratory tract infections, nasal and sinus
problems. Said Moeller, "In the first 60 human cases which we have
record
of, the doctors reported no failures at all. In fact, almost all
conditions
showed full recovery within 1-7 days, and in the case of one eye
infection,
the doctor reported immediate relief.

Malaria Tests

Malaria is reportedly the number two infectious killer in the world,
killing
approximately 1.5 million people, mostly children, annually. An
outbreak of
several new cases was recently reported in the United States in
Virginia. Of
the first 60 patents treated in the hospitals with the ASAP
Solution(R),
there were eight reported malaria patients. Some of the cases were
reported
as having "severe malaria". The patients ages were 8, 18, 35, 45, 51,
53,
56, and 75. The doctors reported that all eight malaria cases were
fully
recovered within just seven days. Said Moeller, "We are very excited
about
the test results and the drug approval. We can now sell the product in
West
Africa and we expect to be shipping hundreds of thousands of bottles
of the
ASAP Solution(R) to Africa before the end of the year. We are just on
the
tip of the iceberg. Thousands of doctors and companies have been
searching
for a treatment for malaria with limited success. Whereas, the test
results
of ASAP Solution(R) are very positive. A new series of human trials
has
already begun in Africa specializing in the treatment of malaria
alone. We
hope to have those results soon. In conjunction with the results we
released
a few weeks ago, showing the products ability to kill the MRSA super
bacteria and the new human test data including the treatment of
malaria, we
feel like the mouse that roared!"